SCHEMBL2806467

SCHEMBL2806467

C[Si](C)(C)O[Si](C)(CCCNC(=O)/C(C#N)=C/C=C(c1ccccc1)c1ccccc1)O[Si](C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 7/20 0.40
HPGD P15428 5/20 0.40
MAPT P10636 5/20 0.39
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
EGFR P00533 3/20 0.39
MAPK1 P28482 3/20 0.39
POLB P06746 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
ALOX15 P16050 2/20 0.39
ALOX12 P18054 2/20 0.39
CYP2C19 P33261 2/20 0.39
RECQL P46063 2/20 0.39
BLM P54132 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2806471 1.00 LMNA (0.40) LMNASMN1; SMN2KDM4EALDH1A1HPGD
Malonic Acid SCHEMBL2415013 0.97 LMNA (0.39) LMNASMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL1576555 0.95 LMNA (0.37) LMNASMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL12496025 0.95 LMNA (0.37) LMNASMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL14488715 0.83 CES2 (0.34) LMNAKDM4EALDH1A1HPGDMAPT
SCHEMBL2409914 0.83 PTAFR (0.35) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL2409916 0.83 PTAFR (0.35) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL4851098 0.83 DNM1 (0.37) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4851091 0.83 DNM1 (0.37) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL14018852 0.83 DNM1 (0.37) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2683351-B1 USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME OREAL (FR) 2019-10-16 EP disclosed
EP-2266531-B1 Cosmetic composition comprising a superabsorbent polymer and an organic UV filter L'ORÉAL (FR) 2017-06-14 EP disclosed
EP-2538914-B1 COSMETIC COMPOSITION COMPRISING A SUPERABSORBENT POLYMER AND AT LEAST A GEMINI SURFACTANT ORÉAL L (FR) 2016-06-15 EP disclosed
US-9364690-B2 Composition comprising a superabsorbent polymer and a gemini surfactant L'OREAL (FR) 2016-06-14 US disclosed
US-20160067160-A1 USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME OREAL (FR) 2016-03-10 US disclosed
US-20150224046-A1 COMPOSITION CONTAINING A SUPERABSORBENT POLYMER AND AN ORGANIC UV SCREENING AGENT L'OREAL (FR) 2015-08-13 US disclosed
EP-2482793-B1 USE OF PIPERIDINE ESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT ORÉAL L (FR) 2015-04-22 EP disclosed
US-8716311-B2 Use of piperidine ester derivative as solvent in cosmetic compositions; cosmetic compositions comprising it L'OREAL (FR) 2014-05-06 US disclosed
US-20140056832-A1 USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME L'OREAL (FR) 2014-02-27 US disclosed
US-20130039963-A1 COMPOSITION COMPRISING A SUPERABSORBENT POLYMER AND A GEMINI SURFACTANT L'OREAL (FR) 2013-02-14 US disclosed
US-20120269746-A1 USE OF CAPROLACTAM DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT L'OREAL (FR) 2012-10-25 US disclosed
US-20100330018-A1 COMPOSITION CONTAINING A SUPERABSORBENT POLYMER AND AN ORGANIC UV SCREENING AGENT L'OREAL (FR) 2010-12-30 US disclosed
EP-2266531-A1 Cosmetic composition comprising a superabsorbent polymer and an organic UV filter L'Oréal (FR) 2010-12-29 EP disclosed
US-20100143276-A1 Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions L'OREAL (FR) 2010-06-10 US disclosed
EP-2193783-A1 Use of an ester derived from 4-carboxy-2-pyrrolidinone as a solvent in cosmetic compositions; cosmetic compositions containing same L'Oreal (FR) 2010-06-09 EP disclosed
US-7439380-B2 Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof L'OREAL (FR) 2008-10-21 US disclosed
US-20070213548-A1 Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof L'OREAL 2007-09-13 US disclosed
US-7229610-B2 Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof L'OREAL (FR) 2007-06-12 US disclosed
US-7229610-B2 Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof L'OREAL (FR) 2007-06-12 US disclosed
US-20050129636-A1 Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof L'OREAL (FR) 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213548-A1 Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof XPA, ERCC4, DCLRE1A LMNA 938/4885SMN1; SMN2 1365/4885KDM4E 2378/4885
US-20050129636-A1 Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof XPA, ERCC4, DCLRE1A LMNA 938/4885SMN1; SMN2 1365/4885KDM4E 2378/4885
US-20140056832-A1 USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME DIMT1, MAT2A, SCD LMNA 2896/4885SMN1; SMN2 2328/4885KDM4E 591/4885
US-20150224046-A1 COMPOSITION CONTAINING A SUPERABSORBENT POLYMER AND AN ORGANIC UV SCREENING AGENT KRT18, FABP2, FABP4 LMNA 1156/4885SMN1; SMN2 4685/4885KDM4E 3344/4885
US-20160067160-A1 USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME DIMT1, FADS2, SCD LMNA 2770/4885SMN1; SMN2 2411/4885KDM4E 591/4885
US-20100330018-A1 COMPOSITION CONTAINING A SUPERABSORBENT POLYMER AND AN ORGANIC UV SCREENING AGENT KRT18, FABP2, FABP4 LMNA 1156/4885SMN1; SMN2 4685/4885KDM4E 3344/4885
US-20120269746-A1 USE OF CAPROLACTAM DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT DEGS1, CAPN1, PPT1 LMNA 274/4885SMN1; SMN2 3359/4885KDM4E 3150/4885
US-20100143276-A1 Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions FASN, ALOX12, PAH LMNA 461/4885SMN1; SMN2 3473/4885KDM4E 148/4885
US-20130039963-A1 COMPOSITION COMPRISING A SUPERABSORBENT POLYMER AND A GEMINI SURFACTANT SGMS2, SGMS1, SCO2 LMNA 2477/4885SMN1; SMN2 2010/4885KDM4E 3100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.